endolysin has been researched along with Bacterial Disease in 14 studies
lysine-4,4,5,5-d4 : A deuterated compound that is lysne in which the methylene hydrogens at positions 4, 4, 5 and 5 have been replaced by deuterium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Endolysins have been studied against a number of drug-resistant pathogens to assess their therapeutic ability." | 2.66 | Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. ( Chhibber, S; Gondil, VS; Harjai, K, 2020) |
| "Another promising approach in combating bacterial infections is genome editing using the CRISPR-Cas systems." | 2.66 | Next-Generation Antibiotics, Bacteriophage Endolysins, and Nanomaterials for Combating Pathogens. ( Abaev, IV; Dyatlov, IA; Filippovich, SY; Firstova, VV; Fursova, NK; Ignatov, SG; Shemyakin, IG, 2020) |
| " In particular, the use of targeted bacteriophage therapy from specialized delivery platforms has shown particular promise owing to the control of delivery location, administration conditions and dosage of the therapeutic cargo." | 2.55 | Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins. ( Hathaway, H; Jenkins, TA; Milo, S; Sutton, JM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Hu, Z | 1 |
| Li, M | 1 |
| Yang, Y | 1 |
| Lu, S | 1 |
| Rao, X | 1 |
| Gondil, VS | 1 |
| Harjai, K | 1 |
| Chhibber, S | 1 |
| Lai, WCB | 1 |
| Chen, X | 1 |
| Ho, MKY | 1 |
| Xia, J | 1 |
| Leung, SSY | 1 |
| Schmelcher, M | 1 |
| Loessner, MJ | 1 |
| Shemyakin, IG | 1 |
| Firstova, VV | 1 |
| Fursova, NK | 1 |
| Abaev, IV | 1 |
| Filippovich, SY | 1 |
| Ignatov, SG | 1 |
| Dyatlov, IA | 1 |
| Hathaway, H | 1 |
| Milo, S | 1 |
| Sutton, JM | 1 |
| Jenkins, TA | 1 |
| Oliveira, H | 1 |
| São-José, C | 1 |
| Azeredo, J | 1 |
| Mirski, T | 1 |
| Lidia, M | 1 |
| Nakonieczna, A | 1 |
| Gryko, R | 1 |
| Knoll, BM | 1 |
| Mylonakis, E | 1 |
| Brüssow, H | 1 |
| Niczyporuk, JS | 1 |
| Bartoszcze, M | 1 |
| Donovan, DM | 1 |
| Borysowski, J | 1 |
| Weber-Dabrowska, B | 1 |
| Górski, A | 1 |
| Hermoso, JA | 1 |
| García, JL | 1 |
| García, P | 1 |
13 reviews available for endolysin and Bacterial Disease
| Article | Year |
|---|---|
Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriophages; Gram-Positive Bacteria; Human | 2023 |
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriophages; Catalytic Domain; Cell Wall; | 2020 |
Bacteriophage-derived endolysins to target gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacteriophages; Endopeptidases; Gram-Negative Bacteria; | 2020 |
Bacteriophage endolysins - extending their application to tissues and the bloodstream.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteriophages; Endopeptidases; Humans | 2021 |
Next-Generation Antibiotics, Bacteriophage Endolysins, and Nanomaterials for Combating Pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriophages; Endopeptidases; Nanostructure | 2020 |
Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins.
Topics: Bacteria; Bacterial Infections; Bacteriophages; Drug Delivery Systems; Endopeptidases; Humans; Phage | 2017 |
Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriophages; Cell Wall; Endopepti | 2018 |
Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Bacterial Infections; Bac | 2019 |
Antibacterial bioagents based on principles of bacteriophage biology: an overview.
Topics: Animals; Bacteria; Bacterial Infections; Bacteriophages; Biological Therapy; Clinical Trials as Topi | 2014 |
[Phage lytic enzymes--new hope in battle against bacterial infections].
Topics: Animals; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Infections; Bacteriophages; Endopeptid | 2007 |
Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Bacteriophages; Cell Wall; Drug Resistance, B | 2007 |
Bacteriophage endolysins as a novel class of antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriophages; Endopeptidases; Huma | 2006 |
Taking aim on bacterial pathogens: from phage therapy to enzybiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriolysis; Bacteriophages; Cell Wall; End | 2007 |
1 other study available for endolysin and Bacterial Disease
| Article | Year |
|---|---|
Phage therapy: quo vadis?
Topics: Animals; Bacteria; Bacterial Infections; Bacteriophages; Biological Therapy; Endopeptidases; Humans | 2014 |